Lv4
610 积分 2023-11-21 加入
Association of immune-related adverse events with survival outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy: a national multicenter retrospective cohort study in China
1个月前
已完结
Pathologic complete response after neoadjuvant immunochemotherapy: persistent recurrence risk highlights the need for stratified management
1个月前
已完结
Lymph node dissection in neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma: A multicenter real-world study
1个月前
已完结
Enhanced Recovery Protocol Versus Conventional Care in Patients Undergoing Esophagectomy for Cancer: Advantages in Clinical and Patient-Reported Outcomes
5个月前
已完结
Lymph Node Dissection in Neoadjuvant Chemoimmunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Real-world Study
5个月前
已完结
Adjuvant immunotherapy for esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy: a multicenter real-world study
5个月前
已完结
Lymph Node Dissection in Neoadjuvant Chemoimmunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Real-world Study
5个月前
已关闭
Patients with complete clinical response after neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: A Markov decision analysis of esophagectomy versus active surveillance
7个月前
已完结
Perioperative outcomes and survival after neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma
7个月前
已完结
Patients with complete clinical response after neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: A Markov decision analysis of esophagectomy versus active surveillance
7个月前
已完结
皖公网安备34019202002308
